《湖北省三级妇幼保健院评审标准(2024年版)》药事管理条款研究  

Research on pharmaceutical management provisions in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province(2024 Edition)

作　　者：赵琳琳 卢圆圆 刘茂昌 金帆 庞良芳 付伟 ZHAO Linlin;LU Yuanyuan;LIU Maochang;JIN Fan;PANG Liangfang;FU Wei(Dept.of Clinical Pharmacy,General Hospital of Central Theater Command,Wuhan 430070,China;Dept.of Pharmacy,Women and Children’s Hospital of Hubei Province,Wuhan 430064,China;Dept.of Pharmacy,Wuhan Children’s Hospital,Wuhan 430019,China;Dept.of Pharmacy,Yichang Women and Children’s Hospital,Hubei Yichang 443000,China;Dept.of Pharmacy,Tongji Hospital,Tongji Medical College of Huazhong University of Science and Technology,Wuhan 430030,China)

机构地区：[1]中部战区总医院临床药学科,武汉430070 [2]湖北省妇幼保健院药学部,武汉430064 [3]武汉儿童医院药学部,武汉430019 [4]宜昌妇幼保健院药学部,湖北宜昌443000 [5]华中科技大学同济医学院附属同济医院药学部,武汉430030

出　　处：《中国药房》2024年第23期2858-2862,共5页China Pharmacy

基　　金：湖北省科技计划一般面上项目(No.2021CFB348);武汉药学会孵化营项目(No.WHPA202301051)。

摘　　要：目的对《湖北省三级妇幼保健院评审标准(2024年版)》(简称《2024版湖北妇幼标准》)中的药事管理条款进行研究。方法阐述《2024版湖北妇幼标准》中药事管理条款和管理细则的制定过程,同时比较其药事管理条款与《三级妇幼保健院评审标准(2016年版)》中药事管理条款的异同,分析其药事管理特有条款的制定依据,并在此基础上提出进一步改进的建议。结果与结论与《三级妇幼保健院评审标准(2016年版)》比较,《2024版湖北妇幼标准》中涉及药事管理的相同点主要体现在:应遵守的相关法律、法规、规章制度及人员要求,药品采购、储备、贮存及召回全流程管理,药品调剂与制剂管理等方面;《2024版湖北妇幼标准》特有条款主要体现在:成立儿童用药工作组,建立儿童专用药品目录,制定结余药品管理制度和超说明书用药管理等方面。药事管理特有条款的制定既符合近年来国家新发布的政策要求,又结合了妇幼保健院的特点和实际情况。但《2024版湖北妇幼标准》应在加强细节管理、强化中药合理应用管理方面进一步完善。OBJECTIVE To study pharmaceutical management provisions in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province(2024 Edition)(hereinafter referred to as 2024 Edition of Hubei Maternal and Child Health Care Standards).METHODS The formulation of pharmaceutical management clauses and management rules in the 2024 Edition of Hubei Maternal and Child Health Care Standards was elaborated and compared with the pharmaceutical management clauses in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals(2016 Edition)to find out their similarities and differences;the basis for the formulation of unique pharmaceutical management clauses was analyzed,so as to propose further improvement suggestions.RESULTS&CONCLUSIONS Compared with the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals(2016 Edition),the similarities in pharmaceutical management in the 2024 Edition of Hubei Maternal and Child Health Care Standards were mainly reflected in the relevant laws,regulations,rules and personnel requirements that should be followed,the full process management of drug procurement,reserve,storage and recall,drug dispensing and formulation management,etc.The unique provisions of the 2024 Edition of Hubei Maternal and Child Care Standards were mainly reflected in the establishment of children’s medication working group,the establishment of a list of children’s specific drugs,the development of surplus drug management system,and the management of off-label drug use,etc.The formulation of unique provisions for pharmaceutical management not only conformed to the newly released policy requirements in recent years,but also combined the characteristics and actual situation of maternal and child health care hospitals.2024 Edition of Hubei Maternal and Child Health Care Standards should be further improved in terms of strengthening detail management and enhancing the rational application management of traditional Chinese medicine.

关 键 词：妇幼保健院 医院评审标准 药事管理 特殊人群 

分 类 号：R951[医药卫生—药学]